Argenta, Boehringer in Drug Discovery Pact

Argenta, a Galapagos NV company that provides drug discovery services from target validation to development candidate nomination, has signed a collaboration agreement with Boehringer Ingelheim. Argenta will apply its respiratory drug discovery services to an undisclosed target in Boehringer’s respiratory disease portfolio.
 
Dr. John Montana, Argenta’s managing director, said, “We are delighted to have secured this contract with Boehringer Ingelheim, one of the world’s leading companies in the development of drugs for respiratory diseases, and it is testament to the strength and depth of Argenta’s integrated drug discovery capabilities and expertise in this therapeutic area. We look forward to a fruitful collaboration leading to the delivery of preclinical candidates against the target of interest.”